AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections
Veteran consumer health and FMCG strategist to lead preventive wellness and nutrition portfolio expansion through innovation and modern trade channels
The decision marks a key step in the centralized EU review process
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
Company’s FY26 EBITDA rses 20% to Rs. 8,475 crore; Net profit grows 15% amid strong operational performance
Sheshadri brings with him extensive leadership experience spanning healthcare, diagnostics, telecom, and consumer goods industries
The competition received over 42 entries from nursing colleges across Maharashtra
Subscribe To Our Newsletter & Stay Updated